Picture of Lineage Cell Therapeutics logo

LCTX — Lineage Cell Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousSmall CapNeutral

Brief: Lineage Cell Therapeutics Presents New Opregen Data For Dry AMD With GA At 2020 American Academy Of Ophthalmology Annual Meeting

Nov 16 (Reuters) - Lineage Cell Therapeutics Inc  LCTX.A :
    * LINEAGE CELL THERAPEUTICS PRESENTS NEW OPREGEN DATA FOR
DRY AMD
WITH GA AT 2020 AMERICAN ACADEMY OF OPHTHALMOLOGY ANNUAL MEETING
    * LINEAGE CELL THERAPEUTICS INC - IMPROVED VISUAL ACUITY
CONTINUES
TO BE OBSERVED IN COHORT 4 PATIENTS
    * LINEAGE CELL THERAPEUTICS INC - FIRST KNOWN CLINICAL
REPORT OF
RETINAL TISSUE REGENERATION PERSISTED TO 23 MONTHS WITH FURTHER
IMPROVEMENT IN VISUAL ACUITY

Source text for Eikon:  ID:nBw8rkXTpa 
Further company coverage:  LCTX.A 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Lineage Cell Therapeutics

See all news